Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Clinical trial evidence reviewed by an independent NICE committee shows that teplizumab can delay the onset of symptomatic type 1 diabetes by an average of nearly 3 years. Teplizumab is the ...

India, May 3 -- The Ministry of Health and Family Welfare has released India's first-ever guidance document on diabetes mellitus in children at the recently concluded National Summit on Best Practices ...

Label expansion enables a rapid-acting inhaled mealtime insulin option for pediatric patients ≥6 years, addressing injection burden amid persistent unmet needs in youth diabetes management.

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.

A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...

Share on Pinterest Are researchers getting closer to functionally curing type 1 diabetes? Image credit: Costfoto/NurPhoto via Getty Images. A woman has undergone a stem-cell therapy made from her own ...

GLP-1 receptor agonists significantly improve metabolic outcomes in type 2 diabetes patients, with notable reductions in HbA1c, body weight, and body fat. External eating behavior may predict greater ...